Hound Partners - THERAVANCE BIOPHARMA INC ownership

THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 111 filers reported holding THERAVANCE BIOPHARMA INC in Q2 2021. The put-call ratio across all filers is 0.38 and the average weighting 0.1%.

Quarter-by-quarter ownership
Hound Partners ownership history of THERAVANCE BIOPHARMA INC
ValueSharesWeighting
Q2 2021$724,000
-14.4%
49,830
-12.9%
0.04%
-38.6%
Q3 2020$846,000
-17.1%
57,200
+35.9%
0.06%
+119.2%
Q1 2018$1,020,00042,0820.03%
Other shareholders
THERAVANCE BIOPHARMA INC shareholders Q2 2021
NameSharesValueWeighting ↓
Madison Avenue Partners, LP 7,012,226$71,104,00015.26%
Newtyn Management, LLC 2,495,860$25,308,0005.56%
Chescapmanager LLC 1,160,503$11,768,0002.74%
Baupost Group 13,419,226$136,071,0002.35%
Weiss Asset Management LP 7,457,060$75,615,0001.86%
Park West Asset Management LLC 1,919,354$19,462,0001.38%
Cannon Global Investment Management, LLC 65,000$659,0001.06%
Oasis Management Co Ltd. 296,960$3,011,0000.51%
Rubric Capital Management LP 356,100$3,611,0000.18%
Sagefield Capital LP 51,600$523,0000.17%
View complete list of THERAVANCE BIOPHARMA INC shareholders